NetScientific (STU:NTK1) Interest Expense : €-0.09 Mil (TTM As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is NetScientific Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. NetScientific's interest expense for the six months ended in Jun. 2023 was € -0.05 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.09 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. NetScientific's Operating Income for the six months ended in Jun. 2023 was € -2.28 Mil. NetScientific's Interest Expense for the six months ended in Jun. 2023 was € -0.05 Mil. NetScientific did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NetScientific Interest Expense Historical Data

The historical data trend for NetScientific's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetScientific Interest Expense Chart

NetScientific Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.03

-0.06

NetScientific Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Interest Expense	Get a 7-Day Free Trial															-0.01	-0.02	-0.02	-0.04	-0.05

NetScientific Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.09 Mil.

NetScientific (STU:NTK1) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NetScientific's Interest Expense for the six months ended in Jun. 2023 was €-0.05 Mil. Its Operating Income for the six months ended in Jun. 2023 was €-2.28 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2023 was €1.40 Mil.

NetScientific's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

NetScientific did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

NetScientific (STU:NTK1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NetScientific PLC (STU:NTK1) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

NSCI:UK

Address

20 Saint Andrew Street, Holborn Circus, London, GBR, EC4A 3AG

Website

https://www.netscientific.net

NetScientific PLC is a transatlantic healthcare technology company. The group is focused on sourcing, funding and commercializing technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people. Its portfolio consists of WANDA Health, an analytics company that uses machine learning to derive a personalized risk score for Congestive Heart Failure patients, Glucosense a provider of a non-invasive glucose monitoring wearable device, Vortex Biosciences which is engaged in circulating tumor cell identification, selection and analysis for disease monitoring and personalized therapeutic prescribing, and Glycotest which provides non-invasive blood tests for liver cancers and fibrosis-cirrhosis.

NetScientific (STU:NTK1) Headlines

No Headlines